KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $60.3 million.

  • Idexx Laboratories' Share-based Compensation fell 9.33% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.2 million, marking a year-over-year decrease of 5.06%. This contributed to the annual value of $60.3 million for FY2024, which is 0.93% up from last year.
  • Per Idexx Laboratories' latest filing, its Share-based Compensation stood at $60.3 million for FY2024, which was up 0.93% from $59.7 million recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Share-based Compensation ranged from a high of $60.3 million in FY2024 and a low of $31.0 million during FY2020.
  • Its 3-year average for Share-based Compensation is $56.6 million, with a median of $59.7 million in 2023.
  • In the last 5 years, Idexx Laboratories' Share-based Compensation fell by 21.20% in 2020 and then skyrocketed by 31.82% in 2022.
  • Yearly analysis of 5 years shows Idexx Laboratories' Share-based Compensation stood at $31.0 million in 2020, then grew by 21.98% to $37.8 million in 2021, then surged by 31.82% to $49.8 million in 2022, then climbed by 20.03% to $59.7 million in 2023, then increased by 0.93% to $60.3 million in 2024.